학술논문

Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living with Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
Document Type
Article
Source
In: Journal of the Pediatric Infectious Diseases Society. (Journal of the Pediatric Infectious Diseases Society, 1 February 2021, 10(2):201-204)
Subject
Language
English
ISSN
20487207
20487193